|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
CA1271477A
(en)
|
1983-11-18 |
1990-07-10 |
John F. Gerster |
1h-imidazo[4,5-c]quinolin-4-amines
|
|
DE3346123A1
(de)
|
1983-12-21 |
1985-06-27 |
Janssen Pharmaceutica, N.V., Beerse |
Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
|
|
US4727064A
(en)
|
1984-04-25 |
1988-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pharmaceutical preparations containing cyclodextrin derivatives
|
|
JPS61277612A
(ja)
*
|
1985-05-31 |
1986-12-08 |
Kiyoshi Morikawa |
接種用徐放性組成物
|
|
US6407079B1
(en)
|
1985-07-03 |
2002-06-18 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
US5736553A
(en)
|
1988-12-15 |
1998-04-07 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
|
|
EP0386960A3
(en)
*
|
1989-03-07 |
1991-10-23 |
American Cyanamid Company |
Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
|
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
US5037986A
(en)
|
1989-03-23 |
1991-08-06 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
|
|
NZ232740A
(en)
*
|
1989-04-20 |
1992-06-25 |
Riker Laboratories Inc |
Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
|
|
CA2044878C
(en)
*
|
1990-08-07 |
2000-12-26 |
Tacey X. Viegas |
Thermally reversible and irreversible gels
|
|
HU217080B
(hu)
|
1990-10-05 |
1999-11-29 |
Minnesota Mining And Manufacturing Co. |
Új eljárás imidazo[4,5-c]kinolin-4-amin-származékok előállítására
|
|
US5175296A
(en)
|
1991-03-01 |
1992-12-29 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
US5648516A
(en)
|
1994-07-20 |
1997-07-15 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
US5525606A
(en)
|
1994-08-01 |
1996-06-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
|
|
US5624677A
(en)
|
1995-06-13 |
1997-04-29 |
Pentech Pharmaceuticals, Inc. |
Controlled release of drugs delivered by sublingual or buccal administration
|
|
US5741908A
(en)
|
1996-06-21 |
1998-04-21 |
Minnesota Mining And Manufacturing Company |
Process for reparing imidazoquinolinamines
|
|
US5693811A
(en)
|
1996-06-21 |
1997-12-02 |
Minnesota Mining And Manufacturing Company |
Process for preparing tetrahdroimidazoquinolinamines
|
|
DE19637209B4
(de)
|
1996-09-12 |
2006-12-14 |
Siemens Ag |
Verfahren zum Steuern des Antriebsstrangs eines Kraftfahrzeugs und integrierte Antriebsstrangsteuerung
|
|
IL129319A0
(en)
|
1996-10-25 |
2000-02-17 |
Minnesota Mining & Mfg |
Immune response modifier compounds for treatment of TH2 mediated and related diseases
|
|
JPH10298181A
(ja)
|
1997-04-25 |
1998-11-10 |
Sumitomo Pharmaceut Co Ltd |
タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤
|
|
WO1999024432A1
(fr)
|
1997-11-12 |
1999-05-20 |
Mitsubishi Chemical Corporation |
Derives de purine et medicament les renfermant en tant qu'ingredient actif
|
|
ATE247654T1
(de)
|
1997-11-28 |
2003-09-15 |
Sumitomo Pharma |
Neue heterozyklische verbindungen
|
|
JP4189048B2
(ja)
|
1997-12-26 |
2008-12-03 |
大日本住友製薬株式会社 |
複素環化合物
|
|
US7001609B1
(en)
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
|
JP2000159767A
(ja)
|
1998-11-26 |
2000-06-13 |
Sumitomo Pharmaceut Co Ltd |
８−ヒドロキシアデニン誘導体の新規製造法
|
|
US20020058674A1
(en)
|
1999-01-08 |
2002-05-16 |
Hedenstrom John C. |
Systems and methods for treating a mucosal surface
|
|
CZ20012446A3
(cs)
|
1999-01-08 |
2002-01-16 |
3M Innovative Properties Company |
Farmaceutický prostředek pro léčbu onemocnění sliznice
|
|
US6486168B1
(en)
|
1999-01-08 |
2002-11-26 |
3M Innovative Properties Company |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
IL131887A0
(en)
|
1999-09-14 |
2001-03-19 |
Dpharm Ltd |
Phospholipid prodrugs of anti-proliferative drugs
|
|
CZ20022353A3
(cs)
|
2000-01-07 |
2003-02-12 |
Universitaire Instelling Antwerpen |
Deriváty purinu, způsob jejich přípravy a jejich použití
|
|
JP3675274B2
(ja)
|
2000-01-27 |
2005-07-27 |
ダイソー株式会社 |
９−（２−ヒドロキシアルキル）プリン誘導体および１−（２−ヒドロキシアルキル）ピリミジン誘導体の製造法
|
|
GB2359747B
(en)
*
|
2000-02-29 |
2002-04-24 |
Maelor Pharmaceuticals Ltd |
Anaesthetic formulations
|
|
US6733764B2
(en)
|
2000-06-14 |
2004-05-11 |
Alain Martin |
Immunostimulator anti-cancer compounds and methods for their use in the treatment of cancer
|
|
EP1182208A3
(en)
|
2000-07-28 |
2002-05-08 |
Roche Diagnostics GmbH |
Composition for DNA transfection
|
|
WO2002023186A2
(en)
|
2000-09-15 |
2002-03-21 |
Virco Bvba |
System and method for optimizing drug therapy for the treatment of diseases
|
|
GB0023008D0
(en)
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
US20020127224A1
(en)
|
2001-03-02 |
2002-09-12 |
James Chen |
Use of photoluminescent nanoparticles for photodynamic therapy
|
|
ES2278016T3
(es)
|
2001-04-09 |
2007-08-01 |
Novartis Vaccines And Diagnostics, Inc. |
Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r).
|
|
JP4331944B2
(ja)
|
2001-04-17 |
2009-09-16 |
大日本住友製薬株式会社 |
新規アデニン誘導体
|
|
EP1440072A4
(en)
|
2001-10-30 |
2005-02-02 |
Conforma Therapeutic Corp |
PURINE ANALOGS HAVING HSP90 INHIBITORY ACTIVITY
|
|
GB0206461D0
(en)
|
2002-03-19 |
2002-05-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
WO2004032829A2
(en)
|
2002-08-15 |
2004-04-22 |
3M Innovative Properties Company |
Immunostimulatory compositions and methods of stimulating an immune response
|
|
US7754728B2
(en)
|
2002-09-27 |
2010-07-13 |
Dainippon Sumitomo Pharma Co., Ltd. |
Adenine compound and use thereof
|
|
JP2004137157A
(ja)
|
2002-10-16 |
2004-05-13 |
Sumitomo Pharmaceut Co Ltd |
新規アデニン誘導体を有効成分として含有する医薬
|
|
CN100387710C
(zh)
|
2003-01-28 |
2008-05-14 |
上海三维生物技术有限公司 |
原发性癌和转移性癌相关的核酸
|
|
US20040265351A1
(en)
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
|
US20050004144A1
(en)
|
2003-04-14 |
2005-01-06 |
Regents Of The University Of California |
Combined use of IMPDH inhibitors with toll-like receptor agonists
|
|
US20050059613A1
(en)
|
2003-07-08 |
2005-03-17 |
Bahram Memarzadeh |
Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
|
|
CA2534241C
(en)
|
2003-07-31 |
2012-05-29 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers
|
|
US20070161582A1
(en)
|
2003-08-08 |
2007-07-12 |
Dusan Mijikovic |
Pharmaceutical compositions and methods for metabolic modulation
|
|
CA2537450C
(en)
|
2003-09-05 |
2012-04-17 |
Anadys Pharmaceuticals, Inc. |
Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
|
|
JP2005089334A
(ja)
|
2003-09-12 |
2005-04-07 |
Sumitomo Pharmaceut Co Ltd |
８−ヒドロキシアデニン化合物
|
|
EA010160B1
(ru)
|
2003-09-18 |
2008-06-30 |
Конформа Терапьютикс Корпорейшн |
Новые гетероциклические соединения - ингибиторы hsp90 и способы их получения
|
|
FR2863890B1
(fr)
|
2003-12-19 |
2006-03-24 |
Aventis Pasteur |
Composition immunostimulante
|
|
AU2005219413A1
(en)
|
2004-03-02 |
2005-09-15 |
Massachusetts Institute Of Technology |
Nanocell drug delivery system
|
|
EP1728792A4
(en)
|
2004-03-26 |
2010-12-15 |
Dainippon Sumitomo Pharma Co |
8-OXOADENINE COMPOUND
|
|
CA2565500A1
(en)
|
2004-05-28 |
2005-12-15 |
Glaxosmithkline Biologicals S.A. |
Vaccine compositions comprising virosomes and a saponin adjuvant
|
|
WO2006054129A1
(en)
|
2004-11-19 |
2006-05-26 |
Institut Gustave Roussy |
Improved treatment of cancer by double-stranded rna
|
|
US8080560B2
(en)
*
|
2004-12-17 |
2011-12-20 |
3M Innovative Properties Company |
Immune response modifier formulations containing oleic acid and methods
|
|
AU2005322843B2
(en)
*
|
2004-12-30 |
2012-03-08 |
3M Innovative Properties Company |
Immune response modifier formulations and methods
|
|
WO2006087538A1
(en)
|
2005-02-16 |
2006-08-24 |
Astrazeneca Ab |
Chemical compounds
|
|
PL1879893T3
(pl)
|
2005-03-21 |
2010-11-30 |
Ferrer Int |
Sposób otrzymywania podstawionych w pozycji 1, związków 1H-imidazo[4,5-c]chinolino-4-aminowych i związki pośrednie
|
|
US20070292418A1
(en)
|
2005-04-26 |
2007-12-20 |
Eisai Co., Ltd. |
Compositions and methods for immunotherapy
|
|
JP2008540396A
(ja)
|
2005-05-04 |
2008-11-20 |
ファイザー・リミテッド |
癌およびｃ型肝炎などのウイルス感染を治療するためのトール様受容体調節薬としての２−アミド−６−アミノ−８−オキソプリン誘導体
|
|
WO2007015877A2
(en)
|
2005-07-20 |
2007-02-08 |
Kalypsys, Inc. |
Inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
JP2009504803A
(ja)
|
2005-08-22 |
2009-02-05 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Ｔｌｒアゴニスト
|
|
EP1939202A4
(en)
|
2005-09-22 |
2010-06-16 |
Dainippon Sumitomo Pharma Co |
NEW COMPOUND OF ADENINE
|
|
JPWO2007034917A1
(ja)
|
2005-09-22 |
2009-03-26 |
大日本住友製薬株式会社 |
新規なアデニン化合物
|
|
US20090192153A1
(en)
|
2005-09-22 |
2009-07-30 |
Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan |
Novel adenine compound
|
|
WO2007034882A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
|
BRPI0616770A2
(pt)
|
2005-09-27 |
2011-06-28 |
Coley Pharm Gmbh |
modulação de respostas imunes mediadas por tlr empregando oligonucleotìdeos adaptadores
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
US20070100146A1
(en)
|
2005-11-03 |
2007-05-03 |
Trevor Dzwiniel |
Process for the preparation of imidazo[4,5-c]-quinolin-4-amines
|
|
US20070264317A1
(en)
*
|
2006-05-15 |
2007-11-15 |
Perrigo Israel Pharmaceuticals Ltd. |
Imiquimod cream formulation
|
|
US8846697B2
(en)
|
2006-05-31 |
2014-09-30 |
The Regents Of The University Of California |
Purine analogs
|
|
AR061839A1
(es)
|
2006-07-07 |
2008-09-24 |
Gilead Sciences Inc |
Compuestos y composiciones farmaceuticas que activan selectivamente a receptores tipo toll 7(tlr7), y uso de los mismos como agentes antivirales
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
WO2008043031A1
(en)
|
2006-10-04 |
2008-04-10 |
Pharmacopeia, Inc. |
6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
|
|
US7902187B2
(en)
|
2006-10-04 |
2011-03-08 |
Wyeth Llc |
6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
|
|
WO2008045529A1
(en)
|
2006-10-12 |
2008-04-17 |
Serenex, Inc. |
Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases
|
|
CN101230064A
(zh)
|
2007-01-22 |
2008-07-30 |
靳广毅 |
9位亚甲基芳基上取代的嘌呤类衍生物
|
|
AU2008227128B2
(en)
|
2007-02-07 |
2012-12-06 |
The Regents Of The University Of California |
Conjugates of synthetic TLR agonists and uses therefor
|
|
HRP20110115T1
(hr)
|
2007-02-19 |
2011-03-31 |
Glaxosmithkline Llc |
Derivati purina kao imunomodulatori
|
|
PT2132209E
(pt)
|
2007-03-19 |
2014-04-15 |
Astrazeneca Ab |
Compostos de 8-oxo-adenina substituídos na posição 9, como moduladores do recetor de tipo ¿toll¿ (tlr7)
|
|
PE20081887A1
(es)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Nuevo compuesto de adenina
|
|
WO2008118763A1
(en)
*
|
2007-03-23 |
2008-10-02 |
Graceway Pharmaceuticals, Llc. |
Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
|
|
EP2170888B1
(en)
|
2007-06-29 |
2015-04-22 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
|
CN101129373B
(zh)
*
|
2007-08-16 |
2010-12-01 |
华中师范大学 |
一种制备咪喹莫特壳聚糖纳米粒的方法
|
|
WO2009035634A2
(en)
|
2007-09-11 |
2009-03-19 |
Activx Biosciences, Inc. |
Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
|
|
WO2009034386A1
(en)
|
2007-09-13 |
2009-03-19 |
Astrazeneca Ab |
Derivatives of adenine and 8-aza-adenine and uses thereof-796
|
|
WO2009091541A1
(en)
*
|
2008-01-15 |
2009-07-23 |
Dow Pharmaceutical Sciences, Inc. |
Imiquimod formulation
|
|
BRPI0907907A2
(pt)
*
|
2008-02-07 |
2015-07-28 |
Univ California |
Método para inibir ou trata câncer de bexiga superficial em um mamífero, e, uso de um agonista de tlr 7
|
|
CN101239980B
(zh)
|
2008-02-18 |
2011-06-22 |
靳广毅 |
免疫受体调节剂偶联体前体和偶联体及其应用
|
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
|
EP2607365A1
(en)
|
2009-02-11 |
2013-06-26 |
The Regents of The University of California |
Toll-like receptor modulators and treatment of diseases
|
|
EA023536B1
(ru)
|
2009-08-07 |
2016-06-30 |
Глаксосмитклайн Байолоджикалс Са |
Производные оксоаденина, конъюгированные с фосфо- или фосфонолипидами
|
|
JP2013525431A
(ja)
|
2010-04-30 |
2013-06-20 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
合成ｔｌｒ７アゴニストのリン脂質結合体の使用
|